A genetic metabolic condition called Phenylketonuria Therapeutics Market affects how the body processes protein. Phenylalanine is an amino acid that patients with PKU are unable to effectively break down, which can result in the accumulation of harmful chemicals in the body. PKU can result in severe intellectual dis.
Phenylketonuria Therapeutics Market is expected to grow with an 8 6% CAGR from 2023 to 2033 fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.